Morel, Elodie <br/><br/>
Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study).  [electronic resource] 

 -  Clinical cardiology  Mar 2018 
 - 300-306 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1932-8737 
<br/><br/><label>Standard No.: </label>10.1002/clc.22884  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Arrhythmogenic Right Ventricular Dysplasia--diagnosis<br/>Cause of Death--trends<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Echocardiography<br/>Female<br/>Follow-Up Studies<br/>France--epidemiology<br/>Heart Ventricles--diagnostic imaging<br/>Humans<br/>Incidence<br/>Magnetic Resonance Imaging, Cine<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Ramipril--administration & dosage<br/>Renin-Angiotensin System--drug effects<br/>Survival Rate--trends<br/>Time Factors<br/>Ventricular Function, Right--drug effects